SHOX2 and lung carcinoma: In recent years, some studies have reported the value of SHOX2 and RASSF1A gene methylation in the clinicopathological diagnosis of lung cancer [6], while there are not many studies on the expression of SHOX2, RASSF1A, and PTGER4 and their methylation under different clinicopathological features in lung cancer patients.